Mix, L., Vogel, W., Besemer, B., Martus, P., Lengerke, C., Bethge, W., Faul, C. (2025). Trial in progress: Safety and feasibility of a venetoclax-augmented treosulfan-based reduced intensity conditioning before allogeneic stem cell transplantation in AML, MDS/AML and higher risk MDS (VeStAL). Blood. https://doi.org/10.1182/blood-2025-6001